Skip to main content
. 2024 Sep 15;14(9):4172–4196. doi: 10.62347/KIVS3169

Table 1.

Classification and therapeutic applications of RTKs

Receptor family Receptor Applications
Epidermal growth factor receptor, EGFR HER1, HER2, HER3, HER4 Non-small cell lung cancer, head and neck tumors, colorectal cancer, pancreatic cancer, breast cancer, ovarian cancer, cervical cancer
Insulin receptor, INSR IGF-I, IGF-II, INSR, INSRR Breast cancer, hematological malignancies, colorectal cancer, lung cancer, cervical cancer
Platelet-derived growth factor receptor, PDGFR PDGFRα, PDGFRβ, CSF-1R, SCFR, FLK2, FLT3 Hypereosinophilic syndrome, mastocytosis, gastrointestinal stromal tumor, epithelial cell tumor, leukemia
Fibroblast growth factor receptor, FGFR FGFR1, FGFR2, FGFR3, FGFR4 Angiogenesis
Vascular endothelial growth factor receptor, VEGFR VEGFR1, VEGFR2, VEGFR3, VEGFR4 Hepatocellular carcinoma, lung cancer, ovarian cancer
Hepatocyte growth factor receptor, HGFR HGFR, MSPR Breast cancer, colorectal cancer, gastric cancer, prostate cancer, renal cell carcinoma
Angiopoietins receptor of Tie family Tie1, Tie2, TEK Hemangioblastoma, epithelial cell tumor, gastric cancer, hepatocellular carcinoma